Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,610 across all filing types
Latest filing 2019-12-09 Fund Information / Fact…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
108年11月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (770 characters), and it appears to be a brief financial data summary rather than a full report or announcement. It does not fit the criteria for Annual Report, Interim Report, Earnings Release, or other detailed filings. It is best classified as Fund Information / Factsheet (FS), which covers brief summaries of key financial facts and market info.
2019-12-09 Chinese
108年11月法人說明會簡報 — 176220191127E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'Third Quarter 2019 Investor Conference November 27, 2019' and contains detailed financial data for the first three quarters of 2019, including income statements, sales distribution, product revenue shares, and future outlook. It is structured as a presentation with agenda, financial statements, business analysis, and outlook, typical of an investor presentation. The document length is 3945 characters, which is relatively short but contains substantive financial data and analysis, not just a brief announcement or certification. There is no indication that this is a full annual report or an interim report filing; rather, it is a presentation given to investors summarizing quarterly results and outlook. Therefore, the most appropriate classification is Investor Presentation (IP).
2019-11-27 Chinese
108年11月法人說明會簡報 — 176220191127M001.pdf
Investor Presentation Classification · 95% confidence The document is titled as a '2019年第三季法人說明會' which translates to '2019 Q3 Institutional Investor Presentation'. It contains detailed financial data for the first three quarters of 2019, including consolidated income statements, sales market distribution, product sales distribution, growth comparisons versus the previous year, and future outlook. The content is structured as a presentation with slides and charts, typical of investor presentations. The document length is 3113 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a brief summary. Therefore, it is not a report publication announcement or a regulatory filing. It is not a full annual report or an interim report in formal filing format but rather a presentation to investors about quarterly performance and outlook. Hence, the most appropriate classification is Investor Presentation (IP).
2019-11-27 Chinese
108年11月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a company's investor presentation meeting, including date, time, location, and links to presentation materials. The key phrase '法人說明會' translates to 'investor presentation' or 'analyst meeting'. The document does not contain financial statements or detailed financial analysis but rather information about the scheduling and content of an investor presentation. Therefore, it fits the category of an Investor Presentation (IP). The document length is short and it provides links to presentation files, consistent with an investor presentation announcement rather than a full report or regulatory filing.
2019-11-27 Chinese
公告本公司受邀參加元大證券舉辦之法人說明會。
Investor Presentation Classification · 95% confidence The document is a short announcement (644 characters) about the company 1762 中化生 being invited to participate in an investor presentation hosted by Yuanta Securities. It specifies the date, time, and location of the event and mentions that the presentation will cover the company's Q3 financial and business information. There is no actual financial data or detailed report content included, only an announcement of the event. According to the 'MENU VS MEAL' rule, this is an announcement of an investor presentation, not the presentation itself. Therefore, the appropriate classification is Investor Presentation (IP). Confidence is high given the clear description and format.
2019-11-26 Chinese
108年第3季財務報告書 — 201904_1762_AIC.pdf
Regulatory Filings
2019-11-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.